Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Chlorpromazine 50mg/5ml oral liquid
0402010D0AAA3A3
|
Chlorpromazine hydrochloride | Chlorpromazine hydrochloride | Central Nervous System | No data available |
|
Chlorpropamide 100mg tablets
0601021E0AAAAAA
|
Chlorpropamide | Chlorpropamide | Endocrine System | No data available |
|
Chlorpropamide 250mg tablets
0601021E0AAABAB
|
Chlorpropamide | Chlorpropamide | Endocrine System | No data available |
|
Chlorpropamide 250mg/5ml oral suspension
0601021E0AAADAD
|
Chlorpropamide | Chlorpropamide | Endocrine System | No data available |
|
Chlorprothixene 50mg tablets
0402010F0AAABAB
|
Chlorprothixene | Chlorprothixene | Central Nervous System | No data available |
|
Chlorquinaldol 3% / Hydrocortisone butyrate 0.1% cream
1304000W0AACACA
|
Hydrocortisone butyrate | Hydrocortisone butyrate | Skin | No data available |
|
Chlorquinaldol 3% / Hydrocortisone butyrate 0.1% ointment
1304000W0AACBCB
|
Hydrocortisone butyrate | Hydrocortisone butyrate | Skin | No data available |
|
Chlortalidone 50mg/5ml oral suspension
0202010F0AAAKAK
|
Chlortalidone | Chlortalidone | Cardiovascular System | No data available |
|
Cholesterol 750mg/5ml oral suspension
0908010D0AAAKAK
|
Cholesterol | Cholesterol | Nutrition and Blood | No data available |
|
Cholesterol powder
190400000AAEDED
|
Generic compound preparation BNF 1904000 | Other single substance preparations | Other Drugs and Preparations | No data available |
|
Cholib 145mg/20mg tablets
0212000AJBBAAAA
|
Cholib | Fenofibrate/simvastatin | Cardiovascular System | No data available |
|
Cholib 145mg/40mg tablets
0212000AJBBABAB
|
Cholib | Fenofibrate/simvastatin | Cardiovascular System | No data available |
|
Cholic acid 250mg capsules
0109010H0AAAEAE
|
Cholic acid | Cholic acid | Gastro-Intestinal System | No data available |
|
Cholic acid 50mg capsules
0109010H0AAAIAI
|
Cholic acid | Cholic acid | Gastro-Intestinal System | No data available |
|
Choline dihydrogen citrate 10% mixture
090602800AACACA
|
Generic compound preparation BNF 0906028 | Other vitamin B preparations | Nutrition and Blood | No data available |
|
Choline salicylate 16% / Glycerol 12.62% ear drops
120101020AAAEAE
|
Other aural preparations | Other aural preparations | Ear, Nose and Oropharynx | No data available |
|
Choline salicylate 21.61% / Glycerol 12.62% ear drops
120101020AAACAC
|
Other aural preparations | Other aural preparations | Ear, Nose and Oropharynx | No data available |
|
ChondroCare Glucosamine & Chondroitin with MSM tablets
091200000BFRRA0
|
Proprietary compound preparation BNF 0912000 | Other health supplement preparations | Nutrition and Blood | No data available |
|
Choragon 5,000unit inj ampoules
0605010D0BEAAAE
|
Choragon | Chorionic gonadotrophin | Endocrine System | No data available |
|
Choriogonadotropin alfa 250microgram inj vials
0605010X0AAAAAA
|
Choriogonadotropin alfa | Choriogonadotropin alfa | Endocrine System | No data available |
|
Choriogonadotropin alfa 250micrograms/0.5ml inj pfs
0605010X0AAABAB
|
Choriogonadotropin alfa | Choriogonadotropin alfa | Endocrine System | No data available |
|
Chorionic gonadotrophin 1,500unit inj ampoules
0605010D0AAACAC
|
Chorion gonadotroph | Chorionic gonadotrophin | Endocrine System | No data available |
|
Chorionic gonadotrophin 10,000unit inj ampoules
0605010D0AAAGAG
|
Chorion gonadotroph | Chorionic gonadotrophin | Endocrine System | No data available |
|
Chorionic gonadotrophin 2,000unit inj ampoules
0605010D0AAADAD
|
Chorion gonadotroph | Chorionic gonadotrophin | Endocrine System | No data available |
|
Chorionic gonadotrophin 2,000unit inj vials
0605010D0AAAHAH
|
Chorion gonadotroph | Chorionic gonadotrophin | Endocrine System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.